How Increasing Cancer Prevalence is Accelerating Rituximab Market...

added blog Health

2026-09-10 06:10:12 -

How Increasing Cancer Prevalence is Accelerating Rituximab Market Expansion

The Rituximab Drug is witnessing strong growth due to the increasing prevalence of hematological cancers and autoimmune diseases, rising adoption of targeted biologic therapies, and the established clinical effectiveness of rituximab. As a monoclonal antibody targeting CD20-positive B cells, rituximab is widely used in the treatment of non-Hodgkin lymphoma, chronic lymphocytic...

0 Comments 0 Shares 86 Views 0 Reviews